정맥내 면역글로불린 시장 보고서(2026년)

Intravenous immunoglobulin (IVIG) is a therapy used to treat individuals with immunodeficiency. It is administered through an intravenous infusion and consists of immunoglobulins collected from healthy individuals and purified to remove any blood-borne infections or impurities.

The main types of intravenous immunoglobulin include Immunoglobulin G (IgG), Immunoglobulin M (IgM), Immunoglobulin A (IgA), Immunoglobulin E (IgE), and Immunoglobulin D (IgD). Immunoglobulin G (IgG) is the most common type found in blood and other body fluids and plays a key role in defending the body against bacterial and viral infections. IgG is used to enhance the body's natural defense mechanisms. IVIG products are distributed through hospital pharmacies, retail pharmacies, and other outlets, and are used in the treatment of conditions such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), primary immunodeficiency diseases, myasthenia gravis, multifocal motor neuropathy, and others. The primary end-users of IVIG include hospitals, clinics, and home care providers.

Tariffs have influenced the intravenous immunoglobulin market by increasing costs of imported raw immunoglobulins and infusion equipment, disrupting supply chains, and affecting production timelines. Hospitals and clinics in regions like North America and Europe, which rely on imported IVIG, are most impacted. Some local manufacturers are leveraging tariffs to expand domestic production and reduce dependency on imports, creating opportunities for cost optimization and innovation in biosimilar and automated infusion solutions.

The intravenous immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides intravenous immunoglobulin market statistics, including intravenous immunoglobulin industry global market size, regional shares, competitors with a intravenous immunoglobulin market share, detailed intravenous immunoglobulin market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous immunoglobulin industry. This intravenous immunoglobulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous immunoglobulin market size has grown strongly in recent years. It will grow from $15.57 billion in 2025 to $16.86 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of primary immunodeficiency diseases, advancements in immunoglobulin purification techniques, increased hospital-based ivig administration, growing awareness about autoimmune disorders, expansion of ivig production facilities.

The intravenous immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $23.44 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for home-based ivig therapy, development of biosimilar ivig products, integration of automated infusion technologies, expanding applications in neurological disorders, growth in emerging markets for immunoglobulin therapies. Major trends in the forecast period include personalized immunoglobulin therapy, home-based ivig administration, biosimilar development and adoption, enhanced purification and safety protocols, automated infusion systems.

The growing geriatric population is expected to drive the expansion of the intravenous immunoglobulin (IVIG) market. The geriatric population refers to individuals aged 65 and older. As people age, their immune system often becomes less effective, leading to a lack of antibodies. This creates a need for immunoglobulins to provide the necessary antibodies, boosting demand for intravenous immunoglobulins. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, projected that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, a 47% increase. During the same period, this age group's share of the total population is expected to rise from 17% to 23%. Consequently, the increasing geriatric population will contribute to the growth of the intravenous immunoglobulin market.

Major companies in the intravenous immunoglobulin (IVIG) market are focusing on introducing innovative products, such as plasma-derived medicines, and seeking approval from federal agencies like the U.S. FDA to gain a competitive advantage. The introduction of FDA-approved IVIG solutions signals the approval of new therapies for treating specific medical conditions. For example, in June 2024, Biotest AG, a Germany-based supplier of plasma proteins and products, announced the FDA approval of Yimmugo for treating primary immunodeficiencies (PIDs). Yimmugo, an intravenous immunoglobulin, contains pooled human plasma-derived immunoglobulin G (IgG), which is essential for immune support in patients with PIDs. The approval reflects the growing demand for plasma-derived therapies, underscoring the need for effective treatments for patients with weakened immune systems. Yimmugo expands Grifols' existing portfolio of intravenous and subcutaneous immunoglobulins, providing additional options for patients dependent on these vital medicines.

In February 2024, Ridgemont Equity Partners, a US-based equity investment firm, acquired American Outcomes Management for an undisclosed amount. This acquisition aligns with Ridgemont's strategic focus on the growing specialty infusion market, which is driven by an aging population with chronic conditions and an increasing demand for at-home treatment options. American Outcomes Management is a US-based provider of intravenous immunoglobulin (IVIG) infusion therapy.

Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

North America was the largest region in the intravenous immunoglobulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous immunoglobulin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravenous immunoglobulin market consists of sales of intravenous immunoglobulin used for treating people with antibody deficiencies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Immunoglobulin Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intravenous immunoglobulin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous immunoglobulin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous immunoglobulin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: IgG (Immunoglobulin G); IgM (Immunoglobulin M); IgA (Immunoglobulin A); IgE (Immunoglobulin E); IgD (Immunoglobulin D)
• 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
• 3) By Application: Hypogammaglobulinemia; Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Primary Immunodeficiency Diseases; Myasthenia Gravis; Multifocal Motor Neuropathy; Other Applications
• 4) By End-User: Hospitals; Clinics; Home Care
• Companies Mentioned: Bio Products Laboratory Limited; Biotest AG; China Biologic Products Holdings Inc.; CSL Behring; Grifols S.A.; Kedrion SpA; Shanghai RAAS Blood Products Co. Ltd.; Octapharma AG; Takeda Pharmaceutical Company Limited; Baxter International Inc.; LFB Biotechnologies SAS; BDI Pharma Inc.; Hualan Biological Engineering Inc.; ADMA Biologics Inc.; Bharat Serums and Vaccines Limited; Sanquin Plasma Products B.V.; Prothya Biosolutions B.V.; Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.; Pfizer Inc.; Kedrion Biopharma; Intas Pharmaceuticals; Octapharma Pharmazeutika Produktionsges.m.b.H.; GC Pharma; Grifols Biologicals Inc.; Kamada Ltd.; LFB USA; Octapharma Plasma Inc.; Panacea Biotec Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Intravenous Immunoglobulin Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Intravenous Immunoglobulin Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Intravenous Immunoglobulin Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Intravenous Immunoglobulin Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
• 4.2. Major Trends
  • 4.2.1 Personalized Immunoglobulin Therapy
  • 4.2.2 Home-Based Ivig Administration
  • 4.2.3 Biosimilar Development And Adoption
  • 4.2.4 Enhanced Purification And Safety Protocols
  • 4.2.5 Automated Infusion Systems

5. Intravenous Immunoglobulin Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Home Care Providers
• 5.4 Specialty Treatment Centers
• 5.5 Research Laboratories

6. Intravenous Immunoglobulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravenous Immunoglobulin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Intravenous Immunoglobulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Intravenous Immunoglobulin Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Intravenous Immunoglobulin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Intravenous Immunoglobulin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravenous Immunoglobulin Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravenous Immunoglobulin Market Segmentation

• 9.1. Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
• 9.2. Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
• 9.3. Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
• 9.4. Global Intravenous Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Care, Specialty Treatment Centers

10. Intravenous Immunoglobulin Market Regional And Country Analysis

• 10.1. Global Intravenous Immunoglobulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Intravenous Immunoglobulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravenous Immunoglobulin Market

• 11.1. Asia-Pacific Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravenous Immunoglobulin Market

• 12.1. China Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravenous Immunoglobulin Market

• 13.1. India Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravenous Immunoglobulin Market

• 14.1. Japan Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravenous Immunoglobulin Market

• 15.1. Australia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravenous Immunoglobulin Market

• 16.1. Indonesia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravenous Immunoglobulin Market

• 17.1. South Korea Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravenous Immunoglobulin Market

• 18.1. Taiwan Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravenous Immunoglobulin Market

• 19.1. South East Asia Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravenous Immunoglobulin Market

• 20.1. Western Europe Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravenous Immunoglobulin Market

• 21.1. UK Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravenous Immunoglobulin Market

• 22.1. Germany Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravenous Immunoglobulin Market

• 23.1. France Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravenous Immunoglobulin Market

• 24.1. Italy Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravenous Immunoglobulin Market

• 25.1. Spain Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravenous Immunoglobulin Market

• 26.1. Eastern Europe Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravenous Immunoglobulin Market

• 27.1. Russia Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravenous Immunoglobulin Market

• 28.1. North America Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravenous Immunoglobulin Market

• 29.1. USA Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravenous Immunoglobulin Market

• 30.1. Canada Intravenous Immunoglobulin Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravenous Immunoglobulin Market

• 31.1. South America Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravenous Immunoglobulin Market

• 32.1. Brazil Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravenous Immunoglobulin Market

• 33.1. Middle East Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravenous Immunoglobulin Market

• 34.1. Africa Intravenous Immunoglobulin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Intravenous Immunoglobulin Market, Segmentation By Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravenous Immunoglobulin Market Regulatory and Investment Landscape

36. Intravenous Immunoglobulin Market Competitive Landscape And Company Profiles

• 36.1. Intravenous Immunoglobulin Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Intravenous Immunoglobulin Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Intravenous Immunoglobulin Market Company Profiles
  • 36.3.1. Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. CSL Behring Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Intravenous Immunoglobulin Market Other Major And Innovative Companies

• Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma

38. Global Intravenous Immunoglobulin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market

40. Intravenous Immunoglobulin Market High Potential Countries, Segments and Strategies

• 40.1 Intravenous Immunoglobulin Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Intravenous Immunoglobulin Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Intravenous Immunoglobulin Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer